Citation Impact

Citing Papers

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Cellular and molecular aspects of neoplastic progression in the mammary gland
1988
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
Pseudomalignant spindle cell proliferations of the urinary bladder
1994
Biology and management of the midgut carcinoid
1993
Histopathologic and Cytochemical Characteristics of Interval Breast Carcinomas from the Stockholm Mammography Screening Project
1992
Genetic instabilities in human cancers
1998 StandoutNature
Interval cancer and survival in a randomized breast cancer screening trial in Stockholm
1992
Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database
2002
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Endocrine Factors in Common Epithelial Ovarian Cancer*
1991
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
2000 Standout
Interval carcinomas of the breast: A group with intermediate outcome
1996
Histopathology and growth rate of interval breast carcinoma: Characterization of different subgroups
1996
Pathological prognostic factors in breast cancer
1999 Standout
Analysis of interval breast carcinomas in a randomized screening trial in Stockholm
1987
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening
2010
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
2016
Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment
2005 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma
1994
An analysis of 8305 cases of carcinoid tumors
2000 Standout
DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma
1996
Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations
2002 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma
2011
Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?
1999
Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws
2002
Prognostic value of nuclear DNA content in medullary thyroid carcinoma
1985
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Tumor DNA Content in the Prognosis of Colorectal Carcinoma
1986 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers
1993
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Breslow thickness and Clark level in melanoma
2000
Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a
1999
Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
2000
Pathologic and Clinical Features Influencing Outcome of Thin Cutaneous Melanoma: Correlation with Newly Proposed Staging System
2000
Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985
1997
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.
1995
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Bisphenol-A and the Great Divide: A Review of Controversies in the Field of Endocrine Disruption
2009 Standout
Flow‐Cytometric DNA analysis in primary breast carcinomas and clinicopthological correlations
1984
Breast Cancer in Men
2002 Standout

Works of K Erhardt being referenced

Does Successful Interferon Treatment of Tumor Patients Require Life-Long Treatment?
1987
Prognostic factors in thin cutaneous malignant melanoma
1994
Comparison Between Histologic Type, Estrogen Receptor, and Nuclear DNA Content in Mammary Carcinoma
1986
Progression of mammary adenocarcinomas as reflected by nuclear DNA content
1984
Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus
1987
Nuclear DNA Content in Squamous Cell Carcinoma, Small Cell Carcinoma, and Bronchiolo-Alveolar Carcinoma of the Lung
1987
Assessment of malignancy potential in so-called interval mammary carcinomas
1985
Prognostic Significance of Nuclear DNA Analysis in Histological Sections in Mammary Carcinoma
1986
Comparison between slide and flow cytophotometric DNA measurements in breast tumors.
1987
Nuclear DNA patterns and survival in metastasizing ileal carcinoids
1987
Prognostic significance of nuclear DNA content in serous ovarian tumors.
1984
DNA distribution pattern in intestinal carcinoid tumors
1986
Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
1987
Rankless by CCL
2026